Preliminary results of anlotinib and niraparib dual therapy evaluation in platinum-resistant recurrent ovarian cancer.Guochen Liu,Jihong Liu, Bingna Xian,Jing Li,Yanling Feng,He Huang,Ting Wan,Qidan Huang,Hua Tu,Haifeng Gu,Zhimin LiuJOURNAL OF CLINICAL ONCOLOGY(2021)引用 2|浏览12暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要